Creative Planning Medicenna Therapeutics Corp. Transaction History

Creative Planning

  • $101 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021
SELL
$2.97 - $4.28 $115,830 - $166,920
-39,000 Closed
0 $0
Q4 2020

Jan 29, 2021
BUY
$3.7 - $5.97 $37,839 - $61,055
10,227 Added 35.54%
39,000 $183,000
Q3 2020

Nov 05, 2020
BUY
$3.55 - $4.67 $102,144 - $134,369
28,773 New
28,773 $119,000

Others Institutions Holding MDNA

# of Institutions
3
Shares Held
863K
Call Options Held
0
Put Options Held
0
View Full List

About Medicenna Therapeutics Corp.

MDNA Quotes by TradingView
  • Ticker MDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,637,504
  • Market Cap $21.6M
  • Description
  • Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...
More about MDNA
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email